Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose metabolic profiling study of dalcetrapib in healthy men
NL-OMON35295Active, not recruiting
- Sponsor
- Roche
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dalcetrapib in coronary arteriosclerosis, sponsored by Roche. Primary endpoints: Total radioactivity in plasma, Total radioactivity in urine and 11 more. Started Oct 2011; status: active, not recruiting.
02
Drugs
dalcetrapib
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON35295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35295.